Matteo Cadossi

Novel universal SARS-CoV DNA vaccine inducing neutralizing antibodies to huCoV-19/WH01, Beta, Delta and Omicron variants and T cells to Bat-CoV

H. Tegel, S. Hober, F. Weber, 2022 .

In Vivo and Ex Vivo Gene Electrotransfer in Ophthalmological Disorders

M. Ronchetti, R. Cadossi, V. D’Alessio, 2022, Biomedicines.

A universal SARS‐CoV DNA vaccine inducing highly cross‐reactive neutralizing antibodies and T cells

H. Tegel, S. Hober, F. Weber, 2022, EMBO molecular medicine.

A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19

P. Ascierto, F. Palombo, A. Manenti, 2022, Molecular Therapy.

A Systematic Review about Imaging and Histopathological Findings for Detecting and Evaluating Electroporation Based Treatments Response

F. Izzo, R. Fusco, V. Granata, 2021, International journal of environmental research and public health.

The SARS-CoV-2 N Protein Is a Good Component in a Vaccine

F. Weber, Ola Tuvesson, A. Mirazimi, 2020, Journal of Virology.

Reduction of muscle contraction and pain in electroporation-based treatments: An overview

R. Fusco, V. D’Alessio, E. Di Bernardo, 2021, World journal of clinical oncology.

Design and Characterization of a Minimally Invasive Bipolar Electrode for Electroporation

F. Izzo, R. Fusco, V. Granata, 2020, Biology.